Maruti Shares Dip Marginally After Q2 Amid Cost Pressures; Analysts Stay Bullish

Maruti’s Q2 Puts Margin Recovery and Demand Strength in Focus

Revenue grew sharply, but higher costs and weaker investment income weighed on profit; brokerages see scope for recovery.

Revenue growth did not translate into higher profit

Maruti Suzuki India reported consolidated net profit of ₹2,466.1 crore for the September quarter, down 26.4% from ₹3,349 crore a year earlier. Revenue from operations, by contrast, rose 26% to around ₹53,355 crore from ₹42,344.2 crore. The divergence highlights how rising sales can still be accompanied by weaker earnings when input costs and other expenses increase.

Higher commodity prices and adverse foreign-exchange movements added to costs, while mark-to-market losses on mutual fund holdings reduced investment income. Higher depreciation and interest expenses also contributed to the profit miss. These factors matter because they show that the quarter’s earnings pressure was not explained by revenue performance alone.

Margins show a mixed picture

EBITDA margin was 8.9%, down 310 basis points year on year but up about 70 basis points from the previous quarter. Price hikes, cost-reduction efforts, lower employee costs and fixed-cost absorption on inventory build supported the sequential improvement. Commodity costs and higher other expenses partly offset those benefits.

The quarter therefore offers two signals: margins have improved from the preceding quarter, but remain under pressure compared with a year earlier. Analysts expect recovery to take time, with steel and copper costs among the risks. A sustained improvement will depend on whether pricing and cost actions can offset input-cost pressures without weakening demand.

A stronger demand outlook supports the bullish case

Management raised its domestic demand outlook, guiding for at least about 10% growth in the second half of the fiscal year. That implies mid-teens volume growth for FY27, compared with an earlier expectation of about 10%. The company had a pending order book of around 270,000 units as of Dussehra, providing support for the near-term volume outlook.

The order book and upgraded outlook help explain why brokerages retained positive ratings despite lowering earnings estimates or target prices. PL Capital upgraded its rating to Buy and raised its target to ₹13,750 from ₹13,150. Antique Stock Broking retained Buy but cut its target to ₹13,560 from ₹15,710, while Elara Capital also kept a Buy rating and reduced its target to ₹15,378 from ₹17,298. These are brokerage estimates, not assured outcomes.

The debate is about how quickly earnings can catch up

Maruti shares fell as much as 1% to ₹11,335.75 in intraday trading on Wednesday, with a broader market selloff also weighing on sentiment. The stock had corrected 15% over two months, a decline some analysts view as reflecting the margin downgrade and creating a more attractive entry point. That assessment rests on expectations of demand resilience and eventual margin improvement.

Investors should weigh that case against continuing commodity inflation, currency-related costs and uncertainty over investment income. Brokerages have cut estimates to account for these pressures, even as they remain constructive. The key test will be whether higher volumes and pricing can translate into better operating profitability over coming quarters.

Key Highlights

• Consolidated Q2 net profit declined 26.4% year on year to ₹2,466.1 crore.
• Revenue from operations rose 26% to around ₹53,355 crore.
• EBITDA margin was 8.9%, down 310 basis points year on year but up about 70 basis points sequentially.
• Management expects at least about 10% domestic growth in the second half, implying mid-teens volume growth for FY27.
• Brokerages retained Buy ratings, while target prices and earnings estimates were adjusted to reflect cost and margin risks.

Investor Note: Maruti’s demand outlook and sequential margin improvement are encouraging, but the profit decline underlines the importance of tracking input costs and margin recovery. Brokerage targets reflect differing assumptions and should not replace an assessment of valuation, execution and risk tolerance.